Quinlin Hanson

Statistics

Publications

Citations

298

H-Index

Active since

2014

Affiliations

National Center for Advancing Translational Sciences(Current)

National Institutes of Health

Frederick National Laboratory for Cancer Research

Iowa State University

Quinlin Hanson is an author at National Center for Advancing Translational Sciences specializing in life sciences, pharmacology, and molecular virology.

ORCID

Publications per year

2014–2025

Publications

Targeting ACE2–RBD Interaction as a Platform for COVID-19 Therapeutics: Development and Drug-Repurposing Screen of an AlphaLISA Proximity Assay

Quinlin Hanson, Kelli M. Wilson, Min Shen et al. · ACS Pharmacology & Translational Science · 2020 · 87 citations · Full text

Medicine, Infectious Diseases, Pharmacology +15

Restricted Motion of the Conserved Immunoglobulin G1 N-Glycan Is Essential for Efficient FcγRIIIa Binding

Ganesh P. Subedi, Quinlin Hanson, Adam W. Barb · Structure · 2014 · 80 citations · Full text

Life Sciences, Immunology, Molecular Biology +8

NNMT inhibition in cancer-associated fibroblasts restores antitumour immunity

Janna Heide, Agnes Julia Bilecz, Samarjit Patnaik et al. · Nature · 2025 · 41 citations · Full text

Medicine, Immunology, Oncology +17

Calmodulin-induced Conformational Control and Allostery Underlying Neuronal Nitric Oxide Synthase Activation

Quinlin Hanson, Jeffrey R Carley, Tyler J. Gilbreath et al. · Journal of Molecular Biology · 2018 · 29 citations

Life Sciences, Neurobiology, Neuroscience +10

Targeting ACE2-RBD interaction as a platform for COVID19 therapeutics: Development and drug repurposing screen of an AlphaLISA proximity assay

Quinlin Hanson, Kelli M. Wilson, Min Shen et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 27 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +17

1–5 of 7